The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
about
Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug developmentCerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study.YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.A meta-analysis of cerebrospinal fluid visinin-like protein-1 in alzheimers disease patients relative to healthy controls and mild cognitive impairment patients.The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromesYKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progressionSystemic infection modifies the neuroinflammatory response in late stage Alzheimer's diseaseCerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disordersK284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression
P2860
Q26749275-D5182125-D32D-4D2B-A5F2-11C07185D15DQ33843517-C1F9943B-960E-413B-8A39-1002873662FAQ36189198-E535F83C-D470-4C66-9439-B425865BEC54Q36439886-A68410CF-5C3E-41E6-B33B-C5BF9EF6BFA7Q37565386-5B1605F2-CC4A-4098-86D7-51FAADC2E095Q38915171-3E22952E-8590-4FB2-A05C-A081315FEB76Q39217840-9848C92D-601A-46B3-9756-D099B694C92AQ40461425-FDD5A784-9F35-42DC-BADC-7E8801AF766DQ42287106-58573181-7EC9-400A-A0B3-FC1D0593C865Q45811351-654E160B-D8D3-4E9D-91FC-B4BA61EAB866Q47141209-F7793E28-62C0-4A1D-8A7F-D33008A80607Q50532647-9D91D9C7-FC55-4CA8-A1ED-78E13F1CFED8Q58614424-1D7EC426-2542-49C7-B0BB-98BC1E44838DQ58742056-3EB907A8-E47C-47B7-A1A3-3EF61EE7E76DQ58760287-71722419-5EFE-4802-A333-29F3CB35B647Q58763366-E721941F-6516-4508-9535-91B415094E0AQ58788519-A6E4F542-B846-41E8-8264-36F47BB0A343
P2860
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Inflammatory Marker YKL-40 ...... or Dementia with Lewy Bodies.
@ast
The Inflammatory Marker YKL-40 ...... or Dementia with Lewy Bodies.
@en
type
label
The Inflammatory Marker YKL-40 ...... or Dementia with Lewy Bodies.
@ast
The Inflammatory Marker YKL-40 ...... or Dementia with Lewy Bodies.
@en
prefLabel
The Inflammatory Marker YKL-40 ...... or Dementia with Lewy Bodies.
@ast
The Inflammatory Marker YKL-40 ...... or Dementia with Lewy Bodies.
@en
P2093
P2860
P921
P1433
P1476
The Inflammatory Marker YKL-40 ...... or Dementia with Lewy Bodies.
@en
P2093
Christer Nilsson
Henrietta M Nielsen
Malin Wennström
Yulia Surova
P2860
P304
P356
10.1371/JOURNAL.PONE.0135458
P407
P577
2015-08-13T00:00:00Z